P328 Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn’s Disease: a two year real-life observational study from Spain

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2021-05, Vol.15 (Supplement_1), p.S352-S353
Main Authors: Rueda Sanchez, J, Cabello Ramirez, M, Camara Baena, S, Keco Huerga, A, Garcia de la Borbolla Serres, J, Castro Fernandez, M, Grande Santamaria, L
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjab076.452